The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELRX PHARMACEUTICALS, INC. CMN | COM | 00444T100 | 424 | 99,959 | SH | SOLE | 99,959 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS INC CMN | COM | 00448Q201 | 591 | 66,704 | SH | SOLE | 66,704 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC CMN | COM | 015351109 | 3,882 | 21,474 | SH | SOLE | 21,474 | 0 | 0 | ||
ALKERMES PLC CMN | COM | G01767105 | 4,570 | 71,022 | SH | SOLE | 71,022 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS, INC. CMN | COM | 02043Q107 | 4,193 | 34,979 | SH | SOLE | 34,979 | 0 | 0 | ||
AMGEN INC. CMN | COM | 031162100 | 852 | 5,550 | SH | SOLE | 5,550 | 0 | 0 | ||
ARRAY BIOPHARMA INC CMN | COM | 04269X105 | 2,307 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
ARRAY BIOPHARMA INC CMN | COM | 04269X105 | 135 | 2,000 | SH | Call | SOLE | 2,000 | 0 | 0 | |
ARROWHEAD RESEARCH CORP CMN | COM | 042797209 | 587 | 82,133 | SH | SOLE | 82,133 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC CMN | COM | 045396108 | 1,252 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
ASTRAZENECA PLC SPONS ADR SPONSORED ADR CMN | COM | 046353108 | 3,186 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BIO TECHNE CORP CMN | COM | 09073M104 | 3,348 | 34,000 | SH | SOLE | 34,000 | 0 | 0 | ||
BIODEL INC CMN | COM | 09064M204 | 670 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
BIOGEN INC. CMN | COM | 09062X103 | 4,546 | 11,254 | SH | SOLE | 11,254 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC CMN | COM | 09061G101 | 4,910 | 35,899 | SH | SOLE | 35,899 | 0 | 0 | ||
CELGENE CORPORATION CMN | COM | 151020104 | 4,441 | 38,375 | SH | SOLE | 38,375 | 0 | 0 | ||
CEPHEID INC CMN | COM | 15670R107 | 3,891 | 63,635 | SH | SOLE | 63,635 | 0 | 0 | ||
CHIMERIX, INC. CMN | COM | 16934W106 | 885 | 19,152 | SH | SOLE | 19,152 | 0 | 0 | ||
CLOVIS ONCOLOGY INC CMN | COM | 189464100 | 4,605 | 52,400 | SH | SOLE | 52,400 | 0 | 0 | ||
CURIS INC CMN | COM | 231269101 | 712 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EPIZYME INC CMN | COM | 29428V104 | 1,737 | 72,379 | SH | SOLE | 72,379 | 0 | 0 | ||
ESPERION THERAPEUTICS INC CMN | COM | 29664W105 | 1,226 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
FLAMEL TECHNOLOGIES SPON ADR SPONSORED ADR CMN | COM | 338488109 | 1,097 | 51,788 | SH | SOLE | 51,788 | 0 | 0 | ||
GILEAD SCIENCES CMN | COM | 375558103 | 496 | 4,234 | SH | SOLE | 4,234 | 0 | 0 | ||
HOLOGIC INCORPORATED CMN | COM | 436440101 | 1,827 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
ILLUMINA, INC. CMN | COM | 452327109 | 4,684 | 21,451 | SH | SOLE | 21,451 | 0 | 0 | ||
INCYTE CORPORATION CMN | COM | 45337C102 | 4,364 | 41,873 | SH | SOLE | 41,873 | 0 | 0 | ||
INFINITY PHARMACEUTICALS INC CMN | COM | 45665G303 | 876 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ISIS PHARMACEUTICALS INC CMN | COM | 464330109 | 3,810 | 66,208 | SH | SOLE | 66,208 | 0 | 0 | ||
JUNO THERAPEUTICS, INC. CMN | COM | 48205A109 | 267 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
JUNO THERAPEUTICS, INC. CMN | COM | 48205A109 | 49 | 50 | SH | Put | SOLE | 50 | 0 | 0 | |
KALOBIOS PHARMACEUTICALS INC CMN | COM | 48344T100 | 358 | 746,467 | SH | SOLE | 746,467 | 0 | 0 | ||
MEDIVATION INC. CMN | COM | 58501N101 | 3,922 | 34,344 | SH | SOLE | 34,344 | 0 | 0 | ||
MERRIMACK PHARMACEUTICALS INC CMN | COM | 590328100 | 890 | 72,009 | SH | SOLE | 72,009 | 0 | 0 | ||
METTLER-TOLEDO INTL CMN | COM | 592688105 | 3,756 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES, INC. CMN | COM | 63009R109 | 925 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
NATIONAL HOLDINGS CORP CMN | COM | 636375206 | 321 | 89,530 | SH | SOLE | 89,530 | 0 | 0 | ||
NEKTAR THERAPEUTICS CMN | COM | 640268108 | 4,603 | 367,963 | SH | SOLE | 367,963 | 0 | 0 | ||
NEPTUNE TECH & BIORES INC. CMN | COM | 64077P108 | 1 | 15 | SH | SOLE | 15 | 0 | 0 | ||
OCERA THERAPEUTICS INC CMN CLASS | COM | 67552A108 | 709 | 186,573 | SH | SOLE | 186,573 | 0 | 0 | ||
PACIRA PHARMACEUTICALS, INC. CMN | COM | 695127100 | 3,324 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | ||
PROSHARES ULTRA NASDAQ BIOTECHNOLOGY ETF | ETF | 74347R214 | 4,842 | 53,568 | SH | SOLE | 53,568 | 0 | 0 | ||
QIAGEN N.V. COMMON SHARES | COM | N72482107 | 3,471 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
RECEPTOS, INC. CMN | COM | 756207106 | 5,345 | 28,124 | SH | SOLE | 28,124 | 0 | 0 | ||
REGENERON PHARMACEUTICAL INC CMN | COM | 75886F107 | 4,468 | 8,759 | SH | SOLE | 8,759 | 0 | 0 | ||
RELYPSA, INC. CMN | COM | 759531106 | 596 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
SEATTLE GENETICS, INC. CMN | COM | 812578102 | 5,050 | 104,339 | SH | SOLE | 104,339 | 0 | 0 | ||
SPDR S&P BIOTECH ETF ETF | COM | 78464A870 | 1,350 | 1,000 | SH | Put | SOLE | 1,000 | 0 | 0 | |
STEMLINE THERAPEUTICS INC CMN | COM | 85858C107 | 883 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
TESARO INC CMN | COM | 881569107 | 1,764 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL INC. CMN | COM | 90400D108 | 922 | 9,000 | SH | SOLE | 9,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP CMN | COM | 91307C102 | 939 | 5,399 | SH | SOLE | 5,399 | 0 | 0 | ||
VERICEL CORP CMN | COM | 92346J108 | 1,293 | 362,157 | SH | SOLE | 362,157 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC CMN | COM | 92532F100 | 4,356 | 35,276 | SH | SOLE | 35,276 | 0 | 0 | ||
WTS/REPROS THERAPEUTICS INC. SERIES B 2.4500 EXP02/07/2016 | WTS | 76028H126 | 456 | 98,000 | SH | Call | SOLE | 98,000 | 0 | 0 | |
XENOPORT INC CMN | COM | 98411C100 | 797 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
ZOGENIX, INC. CMN | COM | 98978L105 | 504 | 300,000 | SH | SOLE | 300,000 | 0 | 0 |